Fee Schedule for Reference Biological Standards and Biological Preparations, 71105 [2014-28226]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 230 / Monday, December 1, 2014 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–28193 Filed 11–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Fee Schedule for Reference Biological
Standards and Biological Preparations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: General notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS) announces that
HHS/CDC has reviewed and updated its
fee schedule for reference biological
standards and biological preparations
required by OMB Circular A–25, User
Charges. This notice also announces
current contact information to obtain
information on the availability of these
products and the fees for these products.
DATES: These fees are effective January
2, 2015.
FOR FURTHER INFORMATION CONTACT: To
obtain information on the current
inventory of reference biological
standards and biological preparations
and the current fee schedule, please
contact the Division of Scientific
Resources, Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
Mailstop C–17, Atlanta, Georgia 30329;
telephone 404–639–3466. Someone will
be available to answer your inquiry
between 8:00 a.m. and 4:30 p.m. Eastern
Time, Monday through Friday, except
on Federal holidays.
SUPPLEMENTARY INFORMATION: On July
22, 2013 HHS/CDC published a Direct
Final Rule (DFR) titled ‘‘Distribution of
Reference Biological Standards and
Biological Preparations (78 FR 43817).
In the DFR, HHS/CDC updated the
agency name, location, and contact
information for persons interested in
obtaining reference biological standards
and biological preparations.
On August 5, 2013, HHS/CDC
published a General Notice (78 FR
47319) to inform the public that HHS/
CDC has reviewed and updated its fee
schedule per the requirements in OMB
Circular A–25 (User Charges) and to
provide contact information to obtain a
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
14:08 Nov 28, 2014
Jkt 235001
current inventory of products and an
up-to-date fee schedule of charges (see
FOR FURTHER INFORMATION CONTACT).
OMB Circular A–25 (User Charges)
requires that agencies review user
charges for agency programs every two
years. This review should include any
adjustment to reflect changes in costs or
market value. HHS/CDC has conducted
a review of the fees charged for
reference biological standards and
biological preparations. Based on this
review, some reagents are being
removed from our inventory because
they are obsolete. No prices have
increased or decreased at this time.
HHS/CDC prepares reference
biological standards and biological
preparations under the authority of 42
CFR Part 7. These regulations describe
how private entities may obtain
reference biological standards and
biological preparations from HHS/CDC
and how charges for these standards and
preparations are determined. Persons
interested in these products should
contact the Division of Scientific
Resources, Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
Mailstop C–17, Atlanta, Georgia 30329;
telephone 404–639–3466, for the current
inventory and fee schedule. Due to the
changing inventory of the unique
biological standards or biological
preparations, some of which are
prepared only upon request, it is best to
contact HHS/CDC to determine the
availability of a particular product.
Dated: November 25, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2014–28226 Filed 11–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 79 FR 32739–32740,
dated June 7, 2014) is amended to
reflect the reorganization of the National
Center for Immunization and
Respiratory Diseases.
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
71105
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and the
mission and function statements for the
Immunization Services Division (CVGB)
and insert the following:
Immunization Services Division
(CVGB). The Immunization Services
Division (ISD) protects individuals and
communities from vaccine-preventable
diseases through provision of federal
funds and contracts to purchase and
distribute vaccine, provision of
technical and financial support of
immunization programs, provider and
public education, and evaluation and
research.
Office of the Director (CVGB1). (1)
Coordinates the division’s program,
policy, scientific activities and provides
leadership for domestic programmatic
activities; (2) links strategies and
priorities of the primarily programfocused ISD branches with other NCIRD
divisions working in the area of
domestic immunizations and vaccinepreventable diseases; (3) facilitates
development and ongoing
implementation of vaccine coverage
surveillance, health services and
economic research, and program
evaluation across the ISD branches; (4)
interfaces with other CDC CIOs working
in the area of immunizations and
vaccine preventable diseases; (5)
provides guidance for the protection of
research subjects, OMB/PRA
compliance, and scientific review and
clearance of manuscripts and other
written materials produced by ISD
branches; (6) provides leadership for
domestic adult immunizations in the
ISD; (7) provides leadership across the
branches with respect to linking
preparedness and response elements to
the overall influenza prevention and
control strategy, and interfaces with
other parts of CDC with this strategy; (8)
represents ISD in other preparedness
activities with vaccines as
countermeasures; (9) in close
coordination with NCIRD’s Office of
Policy, provides policy support to the
ISD; (10) as appropriate, works through
the NCIRD Office of Policy to serve as
liaison to other policy offices, other
government agencies, and external
partners on policy, program, legislative,
and budgetary issues related to ISD; (11)
conducts policy analysis; (12) advises
ISD leadership on policy and
partnership issues and supports Center
efforts in the management of
Congressional and government
relations; (13) manages cross-cutting
policy issues within ISD and, as
appropriate, with other policy offices
within the Center and CDC; (14)
E:\FR\FM\01DEN1.SGM
01DEN1
]]>Agencies
[Federal Register Volume 79, Number 230 (Monday, December 1, 2014)]
[Notices]
[Page 71105]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-28226]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Fee Schedule for Reference Biological Standards and Biological
Preparations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: General notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS) announces that
HHS/CDC has reviewed and updated its fee schedule for reference
biological standards and biological preparations required by OMB
Circular A-25, User Charges. This notice also announces current contact
information to obtain information on the availability of these products
and the fees for these products.
DATES: These fees are effective January 2, 2015.
FOR FURTHER INFORMATION CONTACT: To obtain information on the current
inventory of reference biological standards and biological preparations
and the current fee schedule, please contact the Division of Scientific
Resources, Centers for Disease Control and Prevention, 1600 Clifton
Road NE., Mailstop C-17, Atlanta, Georgia 30329; telephone 404-639-
3466. Someone will be available to answer your inquiry between 8:00
a.m. and 4:30 p.m. Eastern Time, Monday through Friday, except on
Federal holidays.
SUPPLEMENTARY INFORMATION: On July 22, 2013 HHS/CDC published a Direct
Final Rule (DFR) titled ``Distribution of Reference Biological
Standards and Biological Preparations (78 FR 43817). In the DFR, HHS/
CDC updated the agency name, location, and contact information for
persons interested in obtaining reference biological standards and
biological preparations.
On August 5, 2013, HHS/CDC published a General Notice (78 FR 47319)
to inform the public that HHS/CDC has reviewed and updated its fee
schedule per the requirements in OMB Circular A-25 (User Charges) and
to provide contact information to obtain a current inventory of
products and an up-to-date fee schedule of charges (see FOR FURTHER
INFORMATION CONTACT).
OMB Circular A-25 (User Charges) requires that agencies review user
charges for agency programs every two years. This review should include
any adjustment to reflect changes in costs or market value. HHS/CDC has
conducted a review of the fees charged for reference biological
standards and biological preparations. Based on this review, some
reagents are being removed from our inventory because they are
obsolete. No prices have increased or decreased at this time.
HHS/CDC prepares reference biological standards and biological
preparations under the authority of 42 CFR Part 7. These regulations
describe how private entities may obtain reference biological standards
and biological preparations from HHS/CDC and how charges for these
standards and preparations are determined. Persons interested in these
products should contact the Division of Scientific Resources, Centers
for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop C-
17, Atlanta, Georgia 30329; telephone 404-639-3466, for the current
inventory and fee schedule. Due to the changing inventory of the unique
biological standards or biological preparations, some of which are
prepared only upon request, it is best to contact HHS/CDC to determine
the availability of a particular product.
Dated: November 25, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease
Control and Prevention.
[FR Doc. 2014-28226 Filed 11-28-14; 8:45 am]
BILLING CODE 4163-18-P
